Skip to main
ARCT
ARCT logo

Arcturus Therapeutics (ARCT) Earnings Dates & Reports

Arcturus Therapeutics (ARCT) Most Recent Earnings

Report Date
Period EndingQ3 2025
Est. EPS-$0.98
Actual EPS-$0.49
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Arcturus Therapeutics (ARCT) Earnings per Share (EPS) History

Signup for full access
Browse free

Arcturus Therapeutics (ARCT) Latest Earnings

The value each ARCT share was expected to gain vs. the value each share gained.

Arcturus Therapeutics (ARCT) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.49. This exceeded analysts' expectations of -$0.98 by 50.00%, marking a Beat.

For comparison, Arcturus Therapeutics reported EPS of -$0.26 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.78.

Arcturus Therapeutics (ARCT) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025
-$0.78
Q3 2025
-$0.98-$0.49-50.00%
DeckReportListen
Q2 2025
-$0.96-$0.34-64.58%
DeckReportListen
Q1 2025
-$1.10-$0.52-52.73%
DeckReportListen
Q4 2024
-$0.49-$1.11+126.53%
DeckReportListen
View all

Arcturus Therapeutics (ARCT) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Arcturus Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Arcturus Therapeutics (ARCT) Earnings FAQs

Arcturus Therapeutics (ARCT) last reported earnings on Nov 10, 2025 for Q3 2025, posting an EPS of -$0.49, which Beat the estimate of -$0.98 by 50.00%.

For Q3 2025, Arcturus Therapeutics (ARCT) reported an EPS of -$0.49, exceeding analysts' estimate of -$0.98 by 50.00%.

For Q3 2025, Arcturus Therapeutics (ARCT) Beat expectations with an actual EPS of -$0.49 vs. an estimated EPS of -$0.98.

Following the last earnings report on Nov 10, 2025, Arcturus Therapeutics (ARCT)'s stock price moved — from — to —.

The next Arcturus Therapeutics (ARCT) earnings call is scheduled for Mar. 5, 2026, where executives will discuss financial results and outlook.

Arcturus Therapeutics (ARCT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.